Search for: "Pharms v. U.s.*" Results 1 - 20 of 382
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2019)
18 Dec 2019, 9:59 pm by Patent Docs
For example, in Classen Immunotherapies, Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Federal Circuit Affirms Invalidity of Teva's Patent on Rosuvastatin Formulation
1 Dec 2011, 9:22 pm by Aaron Barkoff
Ltd. v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
AstraZeneca Pharmaceuticals LP v. Apotex Corp. (Fed. Cir. 2012)
9 Feb 2012, 3:43 pm by Patent Docs
LP v. [read post]
Patent Docs - http://www.patentdocs.org/
CAFC affirms D. Del. in Cadence v. Exela in case related to acetaminophen
23 Mar 2015, 5:23 pm by Lawrence B. Ebert
Teva Pharm. [read post]
IPBiz - http://ipbiz.blogspot.com/
Judge Andrews: Motion to Dismiss Counterclaims Denied and Motion for Judgment of Invalidity on the Pleadings Granted
31 Jul 2012, 2:08 pm by Robert Vrana
Teva Pharms. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Federal Circuit Patent Law: Quality Control Testing Is Not Patent Infringement; Does Not "Make" a Product as Contemplated Under § 271(g)
4 Dec 2015, 9:50 am
This appeal included a companion case, Momenta Pharms., Inc. v. [read post]
Indiana Intellectual Property Lawyer Blog - http://www.iniplaw.org/
Federal Circuit Holds That Specific Personal Jurisdiction Exists Anywhere an ANDA Applicant Intends to Market its ANDA Product
20 Mar 2016, 6:34 pm by Aaron Barkoff
Acorda Therapeutics v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Federal Circuit Holds That Specific Personal Jurisdiction Exists Anywhere an ANDA Applicant Intends to Market its ANDA Product
20 Mar 2016, 6:34 pm by Aaron Barkoff
Acorda Therapeutics v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Federal Circuit: Section viii Statement Avoids Infringement Under § 271(e)(2)
9 Feb 2012, 9:42 pm by Aaron Barkoff
AstraZeneca Pharms. v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
District Court Dismisses Impax's Declaratory Judgment Complaint in ANDA Case Against Medicis
24 Apr 2008, 9:57 pm
Medicis Pharm., No. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Duke University v. Biomarin. Duke saves two claims on appeal.
25 Apr 2017, 9:25 am by Lawrence B. Ebert
SeeBioMarin Pharm. [read post]
IPBiz - http://ipbiz.blogspot.com/
Federal Circuit Invalidates Pfizer's Latest-Expiring Patent on Celebrex, for Double Patenting
10 Mar 2008, 8:26 am
Pfizer v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Astra v. Apotex: CAFC Affirms Non-infringement of Method of Use Claims
13 Feb 2012, 1:47 pm by Charles A. Gaglia, Jr.
In AstraZeneca Pharms. [read post]
IP Law Alert - http://www.iplawalert.com
District Court Declines to Stay Integrilin Case, Putting Teva At Risk of Forfeiting 180-Day Exclusivity
19 Apr 2010, 11:00 am by Aaron Barkoff
Millenium Pharms. and Schering Corp. v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
CAFC affirms D. Del. in Sanofi v. Watson related to generic Multaq®
11 Nov 2017, 11:00 am by Lawrence B. Ebert
See Senju Pharm. [read post]
IPBiz - http://ipbiz.blogspot.com/
Supreme Court Takes Jack Daniels Trademark Case with Major Free Speech Implications
22 Nov 2022, 6:50 am by jonathanturley
Seuss Enters., L.P. v. [read post]
Jonathan Turley - https://jonathanturley.org/
Federal Circuit Affirms Extension of 30-Month Stay Against Teva's Generic Evista
24 Feb 2009, 2:22 pm by Aaron Barkoff
Teva Pharms. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Supreme Court Sides With Generic Pharmaceutical Companies in Dispute Over Orange Book "Use Codes"
17 Apr 2012, 8:28 pm by Aaron Barkoff
Labs. v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Insurers Have Duty to Defend Opioid Cases According to Ohio Appellate Court
30 Jun 2020, 10:13 am by Lorelie S. Masters and Matt Revis
Masters Pharm., No. [read post]
Hunton Insurance Recovery Blog - https://www.huntoninsurancerecoveryblog.com/
CAFC in Medicines v. Mylan. Claim term limited to the sole portion of the specification that adequately discloses term
6 Apr 2017, 1:35 pm by Lawrence B. Ebert
Ct. 2120,2129 (2014); Geneva Pharms., Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/